Benchmark Raises Nutex Health (NASDAQ:NUTX) Price Target to $60.00

Nutex Health (NASDAQ:NUTX) had its target price boosted by Benchmark from $45.00 to $60.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Separately, Maxim Group raised their target price on shares of Nutex Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday.

Nutex Health Stock Down 8.4 %

Shares of NUTX stock opened at $28.70 on Tuesday. The company has a market capitalization of $156.04 million, a price-to-earnings ratio of -3.06 and a beta of 0.11. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.55 and a current ratio of 1.77. The stock’s 50 day simple moving average is $23.52 and its 200 day simple moving average is $14.22. Nutex Health has a twelve month low of $4.16 and a twelve month high of $39.48.

Insider Activity

In related news, CFO Jon Christian Bates acquired 1,350 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were bought at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the acquisition, the chief financial officer now owns 2,277 shares in the company, valued at $48,864.42. This trade represents a 145.63 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 38.52% of the stock is owned by company insiders.

Hedge Funds Weigh In On Nutex Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new stake in Nutex Health during the third quarter worth $188,000. State Street Corp bought a new position in shares of Nutex Health during the 3rd quarter worth about $225,000. Thompson Davis & CO. Inc. acquired a new stake in shares of Nutex Health during the 3rd quarter valued at about $494,000. Finally, Essex Investment Management Co. LLC acquired a new stake in shares of Nutex Health during the 3rd quarter valued at about $1,579,000. 5.32% of the stock is currently owned by institutional investors.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.